Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA and recently elected president of the American Society of Clinical Oncology (ASCO), discusses the challenge of balancing the needs of the society’s national and international members. Prof Johnson discusses how ASCO has to be accountable to its US members in terms of implementing treatments, reimbursement, and ensuring federal and state policies are followed. For the international members, the challenge is to make sure that they feel integrated and that they have a voice within the society.
Recorded at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting, in Chicago, IL.